Learn More At:www.DoctorVermeulen.com
Northwest Hospital
Gamma Knife Center
Dr. Sandra Vermeulen, M.D.
Swedish Cancer Institute
Northwest Hospital Gamma Knife Center
Seattle, Washington
Learn More At:www.DoctorVermeulen.com
Gamma Knife Centers in the State of Washington
• Seattle, North
• Seattle, Downtown
• Spokane
• “Tacoma”
Learn More At:www.DoctorVermeulen.com
Northwest Hospital
• Founded in 1960
• Non-profit community hospital
• 281 beds
Learn More At:www.DoctorVermeulen.com
Northwest Gamma Knife Center
• First Patient treated in the Summer of 1993
• Approx. 2500 total patients treated
• 3 Radiation Oncologist on site
• 9 Neurosurgeons
Learn More At:www.DoctorVermeulen.com
Tumor Institute Radiation Oncology Group
Members
T. Barnett, J. Blasko, B. Douglas,S. Eulau, P. Grimm, T. Mate, V. Mehta, R. Meier, A. Morris, J. Sylvester, R.Takamyia, A.Tesler, J. Travaglini, S.Vermeulen
Learn More At:www.DoctorVermeulen.com
Northwest Hospital Gamma Knife Center
• 50% -50% ownership between 2 hospitals
• No physician equity ownership
• 40% of the billing is Global
Learn More At:www.DoctorVermeulen.com
Gamma Knife IndicationsTumor Types
1/3 Malignant
1/3 Functional
1/3 Benign
Learn More At:www.DoctorVermeulen.com
Consults and Consents
• All Patients are seen by Neurosurgery and Radiation Oncology before the Gamma Knife Treatment is scheduled
• All other possible treatment options are explored
• If the tumor being treated is malignant, the GK procedure is coordinated with patient’s chemotherapy schedule
Learn More At:www.DoctorVermeulen.com
Gamma Knife Follow-UpMalignant Tumors
• Patient follow-up is through the department of Radiation Oncology
• Malignant tumors are followed with an MRI scan every 2 months for 1-2 year
Learn More At:www.DoctorVermeulen.com
Gamma Knife Follow-UpBenign Tumors and
Functional Cases• Patient follow-up is through the
department of Neurosurgery• Benign tumors are scanned with an MRI
on an every 6 month bases for 3-5 years• AVM are followed angiographically
every year until the nidus occludes• Functional cases rarely return for a
second GK procedure
Learn More At:www.DoctorVermeulen.com
Gamma Knife Referrals
50% of cases are initially seen by Radiation Oncology
Learn More At:www.DoctorVermeulen.com
Gamma Knife Frame Placement
If multiple metastases are present or the patient has had more than one GK procedure, identifying current targets on the most recent scan will aid in frame placement
Learn More At:www.DoctorVermeulen.com
Gamma Knife Procedure
• Pre-scheduled MRI times
• Conscious sedation
• Check anticonvulsant levels day before or morning of the procedure
• Steroids
Learn More At:www.DoctorVermeulen.com
Gamma Knife“Automatic Positioning System”
If there are multiple metastases in vast different locations of the brain, APS will add considerable time to the treatment. As a result, only 1 or 2 cases for that day should be considered.
Learn More At:www.DoctorVermeulen.com
Northwest Hospital Gamma Knife Center Staffing
• 3 Nurses
• 2 Receptions
• 2 Physicist
• 1 research assistant
Learn More At:www.DoctorVermeulen.com
Gamma KnifeClinical Research
• What is the % of symptomatic necrosis and how does this correlate with volume size?
• If the tumor is “too” big, can the treatment be staged?
• What is the lowest effective single fraction dose for treating meningiomas?
Learn More At:www.DoctorVermeulen.com
Prolonged Corticosteroids use in the Treatment of Brain
Metastases with Accelerator Based Radiosurgery compared to Gamma Knife Radiosurgery
S Vermeulen, J Rasis, B Mason
Learn More At:www.DoctorVermeulen.com
Northwest Hospital Gamma Knife Center
Brain metastases experience previously
published in 1996• 288 tumors in 107 patients
• 91% tumor control
• < 5% required continuous steroid support
Learn More At:www.DoctorVermeulen.com
pReference Stereotactic Systems
• Product of Northwest Medical Physics
• Treatment delivery• Multiple arcs, multi-static fields with custom
blocks, multi-leaf collimater field arrangements
• Frameless• Documented < sub millimeter accuracy by an
independent report from MD Anderson Cancer Center in 1997
Learn More At:www.DoctorVermeulen.com
pReference Stereotatic System
Between 11/98 and 1/00, 56 brain metastases in 26 patients were treated at the Swedish Cancer
Institute
Learn More At:www.DoctorVermeulen.com
RTOG 95-05
• Tumor Size• 2.0 cm (2.4 Gy), 2.1-3.0 cm (18 Gy), 3.1-4.0 cm
(15 Gy)
• Max Dose/Prescription Dose < 2
• PITV(volume of prescription isodose /target volume) required to be between
1-2• ACHIEVED IN 44/50 TARGETS OR 88 %
Learn More At:www.DoctorVermeulen.com
Target Characteristics
• 50/23 targets/patients were eligible for review
• Tumor Volume mean 3.9 cc (0.3 – 29.8 cc)
• Iso mean 89.4% (82-100%)• 40/50 or 80% treated with a
single fraction
Learn More At:www.DoctorVermeulen.com
Results
• Mean survival 9 months (range 2-18 m)
• 48/50 or 96% Tumor Control
• 5/50 or 10% complete disappearance of the target on subsequence scans
• 15/23 patients or 65% required continuous steroid support
Learn More At:www.DoctorVermeulen.com
Conclusion
Possibly less than a 20 % dose gradient within the tumor volume contributes to a limited degree of tumor sterilization and complete response resulting in greater steroid use
Learn More At:www.DoctorVermeulen.com
Northwest Gamma Knife
Top Related